Clinical Trial Update: Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing AST-120 with lactulose in hepatic encephalopathy to assess safety and efficacy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• AST-120 (AST-120)
• LACTULOSE (Lactulose)

Snippet

Sponsor: Ocera Therapeutics | Conditions: Hepatic Encephalopathy | Phase 2 | Status: COMPLETED